Insider Trading activities at Rhythm Pharmaceuticals, Inc. (RYTM) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rhythm Pharmaceuticals, Inc. (RYTM) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rhythm Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1649904.

Total stock buying since 2017: $106,961,710.
Total stock sales since 2017: $126,116,516.
Total stock option exercises since 2017: $12,136,023.


 1   2 
36 insiders reported insider trading activities at Rhythm Pharmaceuticals, Inc. (RYTM):
Insider trading activities of Garfield Alastair
Insider trading activities of Tetrault Lynn A.
Insider trading activities of Sandell Scott D
Insider trading activities of Orbimed Capital Gp V Llc
Insider trading activities of Mott David M
Insider trading activities of Isaly Samuel D
Insider trading activities of Gottesdiener Keith Michael
Insider trading activities of Roberts William T.
Insider trading activities of Shah Rajeev M.
Insider trading activities of Baskett Forest
Insider trading activities of Pfizer Inc
Insider trading activities of Van Der Ploeg Leonardus H.t.
Insider trading activities of Foley Todd
Insider trading activities of Bedrosian Camille L
Insider trading activities of Jean Christophe
Insider trading activities of German Christopher Paul
Insider trading activities of Cramer Pamela J.
Insider trading activities of Mpm Bioventures V Llc
Insider trading activities of Mazabraud Yann
Insider trading activities of Barris Peter J
Insider trading activities of Ipsen, S.a.
Insider trading activities of Baker Julian
Insider trading activities of Good Jennifer L
Insider trading activities of Meeker David P
Insider trading activities of Smith Hunter C
Insider trading activities of Shulman Joseph
Insider trading activities of Mcgirr David W J
Insider trading activities of Kerins Patrick J
Insider trading activities of Desikan Nithya
Insider trading activities of Viswanathan Ravi
Insider trading activities of Barrett M James
Insider trading activities of Chien Jennifer
Insider trading activities of Mathers Edward T
Insider trading activities of Arbuckle Stuart A
Insider trading activities of Deerfield Private Design Fund Iii, L.p.
Insider trading activities of Nea 13 Gp, Ltd

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Rhythm Pharmaceuticals, Inc. (RYTM).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 320,194 $22,110,479 396,198 $3,952,922
2024 0 $0 469,036 $23,546,632 408,345 $5,290,133
2023 0 $0 134,498 $4,541,401 156,062 $999,524
2022 0 $0 26,010 $406,309 52,089 $256,636
2021 10,000 $201,710 1,000,000 $25,100,000 9,000 $61,920
2020 0 $0 1,029,686 $24,276,767 96,480 $580,480
2019 0 $0 807,214 $18,867,245 95,215 $588,403
2018 0 $0 238,079 $7,267,683 70,534 $406,005
2017 6,280,000 $106,760,000 0 $0 0 $0


Table 3. Detailed insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-02-01 Cramer Pamela J. (Chief Human Resources Officer) Sale 946 45.06 42,626
2024-02-01 Cramer Pamela J. (Chief Human Resources Officer) Option Ex 2,650 .00 0
2024-02-01 Lee Jennifer Kayden (EVP, Head of North America) Sale 1,492 45.06 67,229
2024-02-01 Lee Jennifer Kayden (EVP, Head of North America) Option Ex 4,513 .00 0
2024-02-01 Smith Hunter C (Chief Financial Officer) Sale 1,616 45.06 72,816
2024-02-01 Smith Hunter C (Chief Financial Officer) Option Ex 4,925 .00 0
2024-02-01 Meeker David P (President and CEO) Sale 4,361 45.06 196,506
2024-02-01 Meeker David P (President and CEO) Option Ex 14,125 .00 0
2023-12-29 Smith Hunter C (Chief Financial Officer) Option Ex 10,500 6.88 72,240
2023-12-28 Shulman Joseph (Chief Technical Officer) Sale 7,926 50.00 396,315
2023-12-28 Shulman Joseph (Chief Technical Officer) Option Ex 6,800 21.38 145,384
2023-12-27 Shulman Joseph (Chief Technical Officer) Sale 5,015 50.01 250,795
2023-12-27 Shulman Joseph (Chief Technical Officer) Option Ex 2,400 21.38 51,312
2023-12-06 Smith Hunter C (Chief Financial Officer) Sale 20,000 40.00 800,000
2023-12-06 Smith Hunter C (Chief Financial Officer) Option Ex 20,000 6.88 137,600
2023-12-05 Smith Hunter C (Chief Financial Officer) Sale 7,026 35.06 246,359
2023-12-05 Smith Hunter C (Chief Financial Officer) Option Ex 7,026 6.88 48,338
2023-11-24 Smith Hunter C (Chief Financial Officer) Sale 10,974 35.02 384,331
2023-11-24 Smith Hunter C (Chief Financial Officer) Option Ex 10,974 6.88 75,501
2023-11-14 Shulman Joseph (Chief Technical Officer) Sale 27,890 32.07 894,320
2023-11-14 Shulman Joseph (Chief Technical Officer) Option Ex 27,890 6.80 189,652
2023-11-14 Lee Jennifer Kayden (EVP, Head of North America) Sale 13,677 32.01 437,814
2023-11-14 Lee Jennifer Kayden (EVP, Head of North America) Option Ex 12,030 6.80 81,804
2023-11-14 Smith Hunter C (Chief Financial Officer) Sale 12,000 30.38 364,572
2023-11-14 Smith Hunter C (Chief Financial Officer) Option Ex 12,000 6.88 82,560
2023-11-03 Lee Jennifer Kayden (EVP, Head of North America) Sale 80 28.00 2,240
2023-11-03 Lee Jennifer Kayden (EVP, Head of North America) Option Ex 80 6.80 544
2023-09-05 Lee Jennifer Kayden (EVP, Head of North America) Sale 6,166 28.05 172,956
2023-09-05 Lee Jennifer Kayden (EVP, Head of North America) Option Ex 4,519 6.80 30,729
2023-08-09 Lee Jennifer Kayden (EVP, Head of North America) Sale 1,718 24.66 42,365
2023-08-09 Lee Jennifer Kayden (EVP, Head of North America) Option Ex 1,718 6.80 11,682
2023-08-07 Lee Jennifer Kayden (EVP, Head of North America) Sale 11,223 24.18 271,349
2023-08-07 Lee Jennifer Kayden (EVP, Head of North America) Option Ex 8,591 6.80 58,418
2023-07-26 Cramer Pamela J. (Chief Human Resources Officer) Sale 930 17.64 16,405
2023-07-26 Cramer Pamela J. (Chief Human Resources Officer) Option Ex 3,125 .00 0
2023-06-16 Smith Hunter C (Chief Financial Officer) Option Ex 2,000 6.88 13,760
2023-03-29 Roberts William T. (Chief Accounting Officer) Sale 912 17.50 15,960
2023-03-29 Roberts William T. (Chief Accounting Officer) Option Ex 2,500 .00 0
2023-02-14 Shulman Joseph (Chief Technical Officer) Sale 554 26.87 14,885
2023-02-14 Chien Jennifer (EVP, Head of North America) Sale 635 26.87 17,062
2023-02-14 Mazabraud Yann (EVP, Head of International) Sale 1,177 27.03 31,814
2023-02-14 Smith Hunter C (Chief Financial Officer) Sale 702 26.87 18,862
2023-02-11 Shulman Joseph (Chief Technical Officer) Option Ex 1,563 .00 0
2023-02-11 Chien Jennifer (EVP, Head of North America) Option Ex 2,031 .00 0
2023-02-11 Mazabraud Yann (EVP, Head of International) Option Ex 2,031 .00 0
2023-02-11 Smith Hunter C (Chief Financial Officer) Option Ex 2,344 .00 0
2023-02-09 Shulman Joseph (Chief Technical Officer) Sale 921 27.66 25,474
2023-02-09 Shulman Joseph (Chief Technical Officer) Option Ex 2,657 .00 0
2023-02-09 Cramer Pamela J. (Chief Human Resources Officer) Sale 834 27.66 23,068
2023-02-09 Cramer Pamela J. (Chief Human Resources Officer) Option Ex 2,344 .00 0
2023-02-09 Chien Jennifer (EVP, Head of North America) Sale 1,192 27.66 32,970
2023-02-09 Chien Jennifer (EVP, Head of North America) Option Ex 3,438 .00 0
2023-02-09 Mazabraud Yann (EVP, Head of International) Sale 1,548 27.66 42,817
2023-02-09 Mazabraud Yann (EVP, Head of International) Option Ex 3,438 .00 0
2023-02-09 Smith Hunter C (Chief Financial Officer) Sale 1,398 27.66 38,668
2023-02-09 Smith Hunter C (Chief Financial Officer) Option Ex 4,063 .00 0
2022-08-19 Cramer Pamela J. (Chief Human Resources Officer) Sale 13,493 24.83 335,031
2022-08-19 Cramer Pamela J. (Chief Human Resources Officer) Option Ex 13,493 19.02 256,636
2022-07-27 Cramer Pamela J. (Chief Human Resources Officer) Sale 901 11.68 10,523
2022-07-26 Cramer Pamela J. (Chief Human Resources Officer) Option Ex 3,125 .00 0
2022-07-01 Smith Hunter C (Chief Financial Officer) Sale 7,547 4.08 30,791
2022-06-30 Smith Hunter C (Chief Financial Officer) Option Ex 25,000 .00 0
2022-03-29 Roberts William T. (Chief Accounting Officer) Sale 1,023 11.13 11,385
2022-03-29 Roberts William T. (Chief Accounting Officer) Option Ex 2,500 .00 0
2022-02-15 Shulman Joseph (Chief Technical Officer) Sale 557 6.10 3,397
2022-02-15 Chien Jennifer (EVP, Head of North America) Sale 722 6.10 4,404
2022-02-15 Mazabraud Yann (EVP, Head of International) Sale 934 6.10 5,697
2022-02-15 Smith Hunter C (Chief Financial Officer) Sale 833 6.10 5,081
2022-02-11 Shulman Joseph (Chief Technical Officer) Option Ex 1,563 .00 0
2022-02-11 Chien Jennifer (EVP, Head of North America) Option Ex 2,032 .00 0
2022-02-11 Mazabraud Yann (EVP, Head of International) Option Ex 2,032 .00 0
2022-02-11 Smith Hunter C (Chief Financial Officer) Option Ex 2,344 .00 0
2021-04-21 Smith Hunter C (Chief Financial Officer) Option Ex 5,000 6.88 34,400
2021-03-30 Meeker David P (President and CEO) Buy 10,000 20.17 201,710
2021-03-15 Foley Todd (Director) Sale 1,000,000 25.10 25,100,000
2021-01-19 Smith Hunter C (Chief Financial Officer) Option Ex 4,000 6.88 27,520
2020-12-03 Shah Rajeev M. Sale 207,604 29.51 6,126,394
2020-12-02 Shah Rajeev M. Sale 30,939 32.37 1,001,340
2020-08-31 Desikan Nithya (Chief Commercial Officer) Sale 25,000 30.00 750,000
2020-08-31 Desikan Nithya (Chief Commercial Officer) Option Ex 25,000 6.88 172,000
2020-08-11 Desikan Nithya (Chief Commercial Officer) Option Ex 14,534 6.88 99,993
2020-07-02 Shah Rajeev M. Sale 44,153 22.04 972,955
2020-07-01 Shah Rajeev M. Sale 25,527 21.87 558,301
2020-06-30 Shah Rajeev M. Sale 61,901 22.15 1,371,230
2020-06-29 Shah Rajeev M. Sale 52,049 22.19 1,155,019
2020-06-26 Shah Rajeev M. Sale 86,706 23.31 2,020,856
2020-06-26 Foley Todd (Director) Sale 300 25.04 7,512
2020-06-25 Shah Rajeev M. Sale 11,568 25.05 289,766
2020-06-25 Foley Todd (Director) Sale 17,947 25.41 456,033
2020-06-24 Foley Todd (Director) Sale 97,388 25.34 2,467,811
2020-06-05 Foley Todd (Director) Sale 1,896 20.00 37,920
2020-06-03 Foley Todd (Director) Sale 18,245 20.27 369,826
2020-06-02 Foley Todd (Director) Sale 15,578 20.23 315,142
2020-06-01 Foley Todd (Director) Sale 10,535 20.08 211,542
2020-05-28 Foley Todd (Director) Sale 19,152 20.19 386,678
2020-05-27 Foley Todd (Director) Sale 10,148 20.13 204,279
2020-05-26 Foley Todd (Director) Sale 44,421 20.47 909,297
2020-05-22 Foley Todd (Director) Sale 26,906 20.13 541,617
2020-05-21 Foley Todd (Director) Sale 25,594 20.25 518,278
2020-05-20 Foley Todd (Director) Sale 10,527 20.01 210,645
2020-05-19 Foley Todd (Director) Sale 2,633 20.00 52,660
2020-05-18 Foley Todd (Director) Sale 21,349 20.00 426,980
2020-05-13 Foley Todd (Director) Sale 1,837 20.04 36,813
2020-05-12 Foley Todd (Director) Sale 24,342 20.23 492,438
2020-05-11 Foley Todd (Director) Sale 22,155 20.34 450,632
2020-05-08 Foley Todd (Director) Sale 6,633 20.05 132,991
2020-05-07 Foley Todd (Director) Sale 200 20.01 4,002
2020-05-06 Foley Todd (Director) Sale 1,626 20.00 32,520
2020-04-29 Foley Todd (Director) Sale 20,397 20.12 410,387
2020-04-28 Foley Todd (Director) Sale 15,826 20.07 317,627
2020-04-01 Foley Todd (Director) Sale 15,462 15.10 233,476
2020-03-31 Foley Todd (Director) Sale 19,108 15.16 289,677
2020-03-30 Smith Hunter C (CFO and Interim CEO) Option Ex 3,900 6.88 26,832
2020-03-26 Foley Todd (Director) Sale 2,300 15.04 34,592
2020-03-20 Foley Todd (Director) Sale 1,100 15.00 16,500
2020-03-19 Foley Todd (Director) Sale 8,200 15.07 123,574
2020-03-18 Foley Todd (Director) Sale 12,781 15.14 193,504
2020-03-17 Foley Todd (Director) Sale 9,653 15.12 145,953
2020-03-13 Smith Hunter C (Chief Financial Officer) Option Ex 3,500 6.88 24,080
2020-03-09 Gottesdiener Keith Michael (CEO & President) Option Ex 3,408 6.14 20,925
2020-02-10 Gottesdiener Keith Michael (CEO & President) Option Ex 6,816 6.14 41,850
2020-01-28 Smith Hunter C (Chief Financial Officer) Option Ex 6,250 6.88 43,000
2020-01-08 Gottesdiener Keith Michael (CEO & President) Option Ex 33,072 4.59 151,800
2019-12-27 Desikan Nithya (Chief Commercial Officer) Sale 35,181 22.79 801,774
2019-12-27 Desikan Nithya (Chief Commercial Officer) Option Ex 35,181 6.88 242,045
2019-12-12 Foley Todd (Director) Sale 3,762 25.01 94,087
2019-12-11 Foley Todd (Director) Sale 13,600 25.14 341,904
2019-12-10 Foley Todd (Director) Sale 41,839 25.36 1,061,037
2019-12-09 Foley Todd (Director) Sale 22,195 25.04 555,762
2019-12-03 Foley Todd (Director) Sale 16,777 22.33 374,630
2019-12-02 Foley Todd (Director) Sale 25,366 22.03 558,812
2019-11-29 Foley Todd (Director) Sale 18,359 22.67 416,198
2019-11-27 Foley Todd (Director) Sale 34,960 22.91 800,933
2019-11-26 Foley Todd (Director) Sale 74,225 23.31 1,730,184
2019-11-25 Foley Todd (Director) Sale 121,343 23.19 2,813,944
2019-11-22 Foley Todd (Director) Sale 102,682 21.91 2,249,762
2019-11-21 Foley Todd (Director) Sale 64,923 20.80 1,350,073
2019-11-20 Foley Todd (Director) Sale 141,365 22.02 3,112,857
2019-08-12 Desikan Nithya (Chief Commercial Officer) Option Ex 14,534 6.88 99,993
2019-07-16 Gottesdiener Keith Michael (CEO and President) Option Ex 7,500 4.59 34,425
2019-07-11 Smith Hunter C (Chief Financial Officer) Option Ex 10,000 6.88 68,800
2019-05-31 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 5,000 25.10 125,500
2019-05-31 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 5,000 4.59 22,950
2019-05-30 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 5,000 25.31 126,550
2019-05-30 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 5,000 4.59 22,950
2019-05-29 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 5,000 25.51 127,550
2019-05-29 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 5,000 4.59 22,950
2019-05-28 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 10,000 25.38 253,800
2019-05-28 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 10,000 5.37 53,650
2019-03-18 Gottesdiener Keith Michael (CEO & President) Sale 2,329 30.27 70,498
2019-03-15 Gottesdiener Keith Michael (CEO & President) Sale 7,961 30.04 239,148
2019-03-14 Gottesdiener Keith Michael (CEO & President) Sale 1,506 30.05 45,255
2019-03-13 Gottesdiener Keith Michael (CEO & President) Sale 7,782 30.06 233,926
2019-02-27 Gottesdiener Keith Michael (CEO and President) Sale 1,814 30.01 54,438
2019-02-26 Gottesdiener Keith Michael (CEO and President) Sale 635 30.13 19,132
2019-02-19 Gottesdiener Keith Michael (CEO and President) Sale 918 30.05 27,585
2019-02-15 Gottesdiener Keith Michael (CEO and President) Sale 12,002 30.02 360,300
2019-02-13 Gottesdiener Keith Michael (CEO and President) Sale 3,934 30.00 118,020
2019-01-31 Smith Hunter C (Chief Financial Officer) Option Ex 3,000 6.88 20,640
2019-01-23 Gottesdiener Keith Michael (CEO and President) Sale 105 30.21 3,172
2019-01-22 Gottesdiener Keith Michael (CEO and President) Sale 15,674 30.05 471,003
2019-01-18 Gottesdiener Keith Michael (CEO & President) Sale 10,115 30.01 303,551
2019-01-16 Gottesdiener Keith Michael (CEO & President) Sale 662 30.00 19,860
2019-01-16 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 200 30.00 6,000
2018-12-03 Gottesdiener Keith Michael (CEO and President) Sale 563 30.00 16,890
2018-11-02 Gottesdiener Keith Michael (CEO and President) Sale 16,500 30.08 496,320
2018-11-02 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 38,000 30.09 1,143,420
2018-11-02 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 28,200 6.08 171,540
2018-09-25 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Sale 31,800 29.72 945,096
2018-09-25 Van Der Ploeg Leonardus H.t. (Chief Scientific Officer) Option Ex 21,800 4.59 100,062
2018-09-05 Smith Hunter C (Chief Financial Officer) Option Ex 3,000 6.88 20,640
2018-08-10 Desikan Nithya (Chief Commercial Officer) Option Ex 14,534 6.88 99,993
2018-05-22 Orbimed Capital Gp V Llc Sale 19,580 30.67 600,518
2018-05-21 Orbimed Capital Gp V Llc Sale 62,500 31.01 1,938,125
2018-05-18 Orbimed Capital Gp V Llc Sale 69,136 30.77 2,127,314
2018-05-09 Gottesdiener Keith Michael (C.E.O. and President) Option Ex 3,000 4.59 13,770
2017-10-10 Deerfield Private Design Fund Iii, L.p. Buy 355,000 17.00 6,035,000
2017-10-10 Mpm Bioventures V Llc (10% Owner) Buy 100,000 17.00 1,700,000
2017-10-10 Viswanathan Ravi (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Foley Todd (Director) Buy 100,000 17.00 1,700,000
2017-10-10 Nea 13 Gp, Ltd (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Meeker David P (Director) Buy 25,000 17.00 425,000
2017-10-10 Ipsen, S.a. (10% Owner) Buy 20,000 17.00 340,000
2017-10-10 Baskett Forest (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Sandell Scott D (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Kerins Patrick J (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Mott David M (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Barrett M James (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Isaly Samuel D (10% Owner) Buy 355,000 17.00 6,035,000
2017-10-10 Barris Peter J (10% Owner) Buy 550,000 17.00 9,350,000
2017-10-10 Pfizer Inc (10% Owner) Buy 40,000 17.00 680,000
2017-10-05 Baker Julian (Other) Buy 885,000 17.00 15,045,000
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of RYTM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rhythm Pharmaceuticals, Inc. (symbol RYTM, CIK number 1649904) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.